• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    4.51 Down 0.09(1.96%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:4.60
    Open:4.60
    Bid:N/A
    Ask:5.05 x 2000
    1y Target Est:7.00
    Beta:2.82
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:4.40 - 4.66
    52wk Range:1.94 - 6.87
    Volume:677,122
    Avg Vol (3m):1,881,180
    Market Cap:387.00M
    P/E (ttm):N/A
    EPS (ttm):-0.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IDRA

    Comparison

    Symbol% ChgMkt Cap
    IDRADown 1.96%387.00M
    DVAXDown 2.50%461.18M
    PFEDown 1.10%204.46B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5,263.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback